A federal judge just invoked Star Trek in a $5 billion patent ruling against Moderna. Here is why the mRNA giant is heading ...

Global mRNA Synthesis and Manufacturing Market OverviewThe global mRNA synthesis and manufacturing market is projected to grow at a compound annual growth rate of approximately 6% during the forecast ...

Breakthrough personalized mRNA vaccine cuts melanoma recurrence risk by 50% when combined with Keytruda, Moderna CEO reveals ...

University of Oklahoma researchers have created a new drug delivery system that helps cancer cells take in much more of a treatment, improving its ability to kill tumors. The findings are published in ...

A shift in leadership failed to save the stock market from the tech selloff this week. This week's stock selloff was a ...

相关研究成果发表在《科学（Science）》合作期刊《研究（Research）》上。

If you are wondering whether Moderna's share price still reflects its underlying worth, it helps to start with the recent ...

A UK bioanalytical technology company has been ranked among the fastest-growing private tech firms, reflecting strong revenue growth and rising adoption of mass photometry tools across academia, ...

The vaccines are tailor-made to target each patient’s unique cancer. Leeches have a long medical history. Here’s what happens ...

Arbutus Biotech (ABUS) heads to a key March Moderna LNP patent trial as imdusiran HBV milestones drive value—get the latest ...

With a shared purpose, we can realize the true promise of CRISPR and improve healthcare, providing hope to more patients with ...

A new study by researchers at Kiel University and MPI-EvolBio describes how more efficient protein production drives the ...